Trial intelligence / Profile preview

Sotagliflozin in adults with type 1 diabetes and heart failure symptoms

ISRCTN79322795Phase 2Recruiting

Sponsor
University of Dundee
Start
Jan 2025
Modality
Small Molecules
01

Overview

Phase 2, randomised trial of sotagliflozin in heart failure (HF) and diabetes mellitus type 1 (T1D), sponsored by University of Dundee. Started Jan 2025; status: recruiting.

02

Drugs

sotagliflozin
03

Conditions

heart failure (HF)diabetes mellitus type 1 (T1D)

Beyond the preview

Go deeper on ISRCTN79322795.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN79322795.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call